Cargando…

Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report

INTRODUCTION: Pulmonary arterial hypertension is a complication of systemic lupus erythematosus. Mortality in pregnant patients with pulmonary arterial hypertension related to connective tissue disease is as high as 56%. The authors report the first case of a successful maternal-fetal outcome in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Streit, Michael, Speich, Rudolf, Fischler, Manuel, Ulrich, Silvia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726506/
https://www.ncbi.nlm.nih.gov/pubmed/19830150
http://dx.doi.org/10.4076/1752-1947-3-7255
_version_ 1782170613809414144
author Streit, Michael
Speich, Rudolf
Fischler, Manuel
Ulrich, Silvia
author_facet Streit, Michael
Speich, Rudolf
Fischler, Manuel
Ulrich, Silvia
author_sort Streit, Michael
collection PubMed
description INTRODUCTION: Pulmonary arterial hypertension is a complication of systemic lupus erythematosus. Mortality in pregnant patients with pulmonary arterial hypertension related to connective tissue disease is as high as 56%. The authors report the first case of a successful maternal-fetal outcome in a pregnant patient with systemic lupus erythematosus-associated pulmonary arterial hypertension treated with sildenafil and inhaled iloprost during pregnancy and until several weeks after caesarean section. CASE PRESENTATION: The case presented is of a 29-year-old woman with systemic lupus erythematosus and associated severe pulmonary arterial hypertension. Vasodilator therapy with bosentan and sildenafil, immunosuppressive therapy with prednisone, hydroxychloroquine and azathioprine and oral anticoagulation (phenprocoumon) had normalized her right ventricular over right atrial pressure when she was diagnosed in her 5th week of pregnancy. The teratogenic drugs bosentan and phenprocoumon were stopped, the latter replaced by low molecular weight heparin. During the 35th week, a slight increase in pulmonary pressure was found. Therapy with inhaled iloprost was established. A caesarean section was performed in the 37th week and a healthy baby was delivered. The patient remained stable until 11 weeks after delivery, when an increase in right ventricular over right atrial pressure was noted. Bosentan was reintroduced and prednisone and azathioprine doses were increased. The patient has remained stable until the present time. CONCLUSION: Pulmonary arterial hypertension has been considered a contraindication for pregnancy. Novel vasodilator therapy, combined with immunosuppressants in this patient with systemic lupus erythematosus, may "cure" pulmonary arterial hypertension and permit pregnancy with successful outcome. However, postpartum exacerbation of systemic lupus erythematosus and pulmonary arterial hypertension have to be considered.
format Text
id pubmed-2726506
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27265062009-10-14 Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report Streit, Michael Speich, Rudolf Fischler, Manuel Ulrich, Silvia J Med Case Reports Case report INTRODUCTION: Pulmonary arterial hypertension is a complication of systemic lupus erythematosus. Mortality in pregnant patients with pulmonary arterial hypertension related to connective tissue disease is as high as 56%. The authors report the first case of a successful maternal-fetal outcome in a pregnant patient with systemic lupus erythematosus-associated pulmonary arterial hypertension treated with sildenafil and inhaled iloprost during pregnancy and until several weeks after caesarean section. CASE PRESENTATION: The case presented is of a 29-year-old woman with systemic lupus erythematosus and associated severe pulmonary arterial hypertension. Vasodilator therapy with bosentan and sildenafil, immunosuppressive therapy with prednisone, hydroxychloroquine and azathioprine and oral anticoagulation (phenprocoumon) had normalized her right ventricular over right atrial pressure when she was diagnosed in her 5th week of pregnancy. The teratogenic drugs bosentan and phenprocoumon were stopped, the latter replaced by low molecular weight heparin. During the 35th week, a slight increase in pulmonary pressure was found. Therapy with inhaled iloprost was established. A caesarean section was performed in the 37th week and a healthy baby was delivered. The patient remained stable until 11 weeks after delivery, when an increase in right ventricular over right atrial pressure was noted. Bosentan was reintroduced and prednisone and azathioprine doses were increased. The patient has remained stable until the present time. CONCLUSION: Pulmonary arterial hypertension has been considered a contraindication for pregnancy. Novel vasodilator therapy, combined with immunosuppressants in this patient with systemic lupus erythematosus, may "cure" pulmonary arterial hypertension and permit pregnancy with successful outcome. However, postpartum exacerbation of systemic lupus erythematosus and pulmonary arterial hypertension have to be considered. BioMed Central 2009-06-09 /pmc/articles/PMC2726506/ /pubmed/19830150 http://dx.doi.org/10.4076/1752-1947-3-7255 Text en Copyright ©2009 licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case report
Streit, Michael
Speich, Rudolf
Fischler, Manuel
Ulrich, Silvia
Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
title Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
title_full Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
title_fullStr Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
title_full_unstemmed Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
title_short Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
title_sort successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726506/
https://www.ncbi.nlm.nih.gov/pubmed/19830150
http://dx.doi.org/10.4076/1752-1947-3-7255
work_keys_str_mv AT streitmichael successfulpregnancyinpulmonaryarterialhypertensionassociatedwithsystemiclupuserythematosusacasereport
AT speichrudolf successfulpregnancyinpulmonaryarterialhypertensionassociatedwithsystemiclupuserythematosusacasereport
AT fischlermanuel successfulpregnancyinpulmonaryarterialhypertensionassociatedwithsystemiclupuserythematosusacasereport
AT ulrichsilvia successfulpregnancyinpulmonaryarterialhypertensionassociatedwithsystemiclupuserythematosusacasereport